ArticleCancer immunology, immunotherapy : CII2013

CD137 stimulation and p38 MAPK inhibition improve reactivity in an in vitro model of glioblastoma immunotherapy.

Caspar Kühnöl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.